Effectiveness of Qingre Lishi Yishen decoction on the glomerular fibrosis of immunoglobulin A nephropathy in a rat's model

被引:0
作者
Dang Wanyu [1 ]
Hou Linyi [1 ]
Yan Huimin [1 ]
Yan Xiaoming [1 ]
Zhen Xiaofang [1 ]
Hao Jing [1 ]
机构
[1] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Tradit Chinese Med, Beijing 100045, Peoples R China
关键词
Glomerulonephritis; IGA; Mesangial cells; Fibronectins; Tumor necrosis factor-alpha; Qingre Lishi Yishen decoction; IGA1-CONTAINING IMMUNE-COMPLEXES; IGA NEPHROPATHY; MESANGIAL CELL; GLYCOSYLATION; ANTIBODIES; ACTIVATION; INJURY;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To investigate the effect of the clinical effective prescription of Qingre Lishi Yishen decoction (QRLS) on the activation of mesangial cells in immunoglobulin A nephropathy (IgAN) rats. METHODS: IgAN rat's model was established by combine with intragastric administration of bovine serum albumin (BSA) + intravenous injection of lipopolysaccharide (LPS) by + subcutaneous injection of carbon tetrachloride (CCL4). Then the animals were randomly divided into four groups: control group, IgAN model group, IgAN model with Valsartan (Val) treatment group and IgAN model with QRLS treatment group. To observe the indexes of 24-h urine protein, renal function, deposition of immune complexes, expression of activation factor, fibrosis marker and inflammatory cytokines in four different groups. RESULTS: The Val or QRLS treatment group: (a) it reduced the immune complexes deposition of IgA in glomerular mesangial and inhibited mesangial cell proliferation; (b) it decreased the expression of smooth muscle actin (alpha-SMA), fibronectin (FN) and tumor necrosis factor alpha (TNF-alpha). CONCLUSION: The study suggested that QRLS ameliorate renal structure and function in IgAN rat's model. Furthermore, we also observed that QRLS alleviated mesangial cells activation and matrix accumulation partly by decreasing the alpha-SMA, then to downregulated the expression of FN and TNF-alpha. (C) 2019 JTCM. All rights reserved.
引用
收藏
页码:516 / 523
页数:8
相关论文
共 33 条
[1]   Mesangial cell biology [J].
Abboud, Hanna E. .
EXPERIMENTAL CELL RESEARCH, 2012, 318 (09) :979-985
[2]   Primary IgA Nephropathy: New Insights Into Pathogenesis [J].
Barrett, Jonathan ;
Feehally, John .
SEMINARS IN NEPHROLOGY, 2011, 31 (04) :349-360
[3]  
Berger J, 1968, J Urol Nephrol (Paris), V74, P694
[4]   An update on the pathogenesis and treatment of IgA nephropathy [J].
Boyd, Joanna K. ;
Cheung, Chee K. ;
Molyneux, Karen ;
Feehally, John ;
Barratt, Jonathan .
KIDNEY INTERNATIONAL, 2012, 81 (09) :833-843
[5]   Role of matrix metalloproteinases in renal pathophysiologies [J].
Catania, J. M. ;
Chen, G. ;
Parrish, A. R. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (03) :F905-F911
[6]   BMP-7 protects mesangial cells from injury by polymeric IgA [J].
Chan, Wai Long ;
Leung, Joseph C. K. ;
Chan, Loretta Y. Y. ;
Tam, K. Y. ;
Tang, Sydney C. W. ;
Lai, Kar Neng .
KIDNEY INTERNATIONAL, 2008, 74 (08) :1026-1039
[7]   Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes [J].
Coppo, Rosanna ;
Fonsato, Valentina ;
Balegno, Sabrina ;
Ricotti, Emanuela ;
Loiacono, Elisa ;
Camilla, Roberta ;
Peruzzi, Licia ;
Amore, Alessandro ;
Bussolati, Benedetta ;
Camussi, Giovanni .
KIDNEY INTERNATIONAL, 2010, 77 (05) :417-427
[8]   Crosstalk in glomerular injury and repair [J].
Dimke, Henrik ;
Maezawa, Yoshiro ;
Quaggin, Susan E. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (03) :231-238
[9]   IgA nephropathy [J].
Donadio, JV ;
Grande, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (10) :738-748
[10]  
Emancipator SN, 2011, CONTRIB NEPHROL, V169, P126, DOI 10.1159/000319124